UBS Group’s Cel-Sci Corp Series S CVM.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-31,494
| Closed | – | – | 8681 |
|
|
2018
Q3 | $0 | Buy |
+31,494
| New | +$397 | ﹤0.01% | 8531 |
|
|
2017
Q4 | – | Sell |
-68,433
| Closed | -$2K | – | 8318 |
|
|
2017
Q3 | $2K | Buy |
+68,433
| New | +$2.96K | ﹤0.01% | 7524 |
|
|
2017
Q2 | – | Sell |
-700
| Closed | – | – | 8241 |
|
|
2017
Q1 | $0 | Buy |
+700
| New | +$23 | ﹤0.01% | 8246 |
|
|
2016
Q4 | – | Sell |
-3,524
| Closed | – | – | 8258 |
|
|
2016
Q3 | $0 | Buy |
+3,524
| New | +$572 | ﹤0.01% | 8149 |
|
|
2016
Q2 | – | Sell |
-3,142
| Closed | -$1K | – | 8158 |
|
|
2016
Q1 | $1K | Buy |
+3,142
| New | +$616 | ﹤0.01% | 7509 |
|
|
2015
Q4 | – | Sell |
-3,221
| Closed | -$1K | – | 8733 |
|
|
2015
Q3 | $1K | Sell |
3,221
-36,850
| -92% | -$8.3K | ﹤0.01% | 8286 |
|
|
2015
Q2 | $8K | Buy |
40,071
+36,231
| +944% | +$8.6K | ﹤0.01% | 7640 |
|
|
2015
Q1 | $1K | Sell |
3,840
-2,382
| -38% | -$537 | ﹤0.01% | 8625 |
|
|
2014
Q4 | $1K | Buy |
+6,222
| New | +$1K | ﹤0.01% | 9589 |
|
UBS Group's CVM.WS Position: Q4 2018 in Review
UBS Group sold out of Cel-Sci Corp Series S (CVM.WS) in Q4 2018, closing a stake of 31,494 shares.
UBS Group first reported a position in CVM.WS in Q4 2014 and held it in 9 quarters. The position peaked at $8K in Q2 2015. 0 funds tracked by Wall St. Rank hold CVM.WS as of Q4 2018.
- UBS Group reported no remaining Cel-Sci Corp Series S position as of Q4 2018 after selling out during the quarter.
- UBS Group sold 31,494 Cel-Sci Corp Series S shares in Q4 2018.
- UBS Group first reported a position in Cel-Sci Corp Series S in Q4 2014 and held it in 9 quarters.
- UBS Group's Cel-Sci Corp Series S position peaked at $8K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Cel-Sci Corp Series S as of Q4 2018.
Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.